News | March 09, 2023
Ashland Hyderabad laboratory receives ISO certification
Ashland’s pharmaceutical business is well known for acetylenics, cellulosics, and film coatings
Ashland’s pharmaceutical business is well known for acetylenics, cellulosics, and film coatings
The voluntary program is the first time the FDA will allow excipient manufacturers to obtain review of certain novel excipients prior to their use in drug formulations.
The need for hot-melt extrusion (HME) polymers is expected to grow as the pharma industry moves to implement more continuous and sustainable processes.
The capital expansion program commenced in June 2022 and is expected to complete in 2024
Under the agreement, Univar Solutions customers in Brazil and Mexico will have access to Ashland's binders and disintegrants for solid dosage forms, matrix formers for modulated release drugs and coatings for regular and modulated release solid dosage forms
The science leader comes with a rich experience in the employment testing industry
The kidney care provider has established over 40 dialysis centres, delivering more than 40,000 dialysis sessions
The approval enables the company to directly sell health insurance plans to individuals and families while integrating its managed healthcare delivery model into retail offerings
This linear, covalently closed, double-stranded DNA offers a rapid, cell-free alternative to traditional plasmid DNA, addressing a critical bottleneck in nucleic acid therapeutics development
Clinical trials found that 77% of patients went into remission after receiving obe-cel
Subscribe To Our Newsletter & Stay Updated
